O
NVRO

OrbiMed’s NEVRO CORP. NVRO Stock Holding History

OrbiMed’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,357,691
Closed -$77.4M – 156
2018
Q3 		$77.4M Buy
1,357,691
+97,600
+8% +$6.1M 0.94% 28
2018
Q2 		$101M Hold
1,260,091
– – 1.21% 28
2018
Q1 		$109M Buy
1,260,091
+362,300
+40% +$29.3M 1.36% 21
2017
Q4 		$62M Buy
897,791
+402,891
+81% +$32.2M 0.79% 41
2017
Q3 		$45M Buy
494,900
+43,600
+10% +$3.73M 0.43% 64
2017
Q2 		$33.6M Buy
451,300
+373,500
+480% +$29.9M 0.35% 70
2017
Q1 		$7.29M Buy
+77,800
New +$7.05M 0.08% 106

Other funds holding NVRO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return